These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7491657

  • 1. HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat.
    Belayev L, Busto R, Zhao W, Ginsberg MD.
    Stroke; 1995 Dec; 26(12):2313-9; discussion 2319-20. PubMed ID: 7491657
    [Abstract] [Full Text] [Related]

  • 2. MRZ 2/579, a novel uncompetitive N-methyl-D-aspartate antagonist, reduces infarct volume and brain swelling and improves neurological deficit after focal cerebral ischemia in rats.
    Liu Y, Belayev L, Zhao W, Busto R, Ginsberg MD.
    Brain Res; 2000 Apr 17; 862(1-2):111-9. PubMed ID: 10799675
    [Abstract] [Full Text] [Related]

  • 3. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.
    Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD.
    Stroke; 1996 Sep 17; 27(9):1616-22; discussion 1623. PubMed ID: 8784138
    [Abstract] [Full Text] [Related]

  • 4. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
    Tatlisumak T, Takano K, Meiler MR, Fisher M.
    Stroke; 1998 Jan 17; 29(1):190-5. PubMed ID: 9445350
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats.
    Huh PW, Belayev L, Zhao W, Clemens JA, Panetta JA, Busto R, Ginsberg MD.
    Eur J Pharmacol; 2000 Feb 11; 389(1):79-88. PubMed ID: 10686299
    [Abstract] [Full Text] [Related]

  • 6. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
    Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD.
    Stroke; 2001 Feb 11; 32(2):553-60. PubMed ID: 11157196
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
    Belayev L, Khoutorova L, Deisher TA, Belayev A, Busto R, Zhang Y, Zhao W, Ginsberg MD.
    Stroke; 2003 Mar 11; 34(3):758-63. PubMed ID: 12624304
    [Abstract] [Full Text] [Related]

  • 8. CP-0597, a selective bradykinin B2 receptor antagonist, inhibits brain injury in a rat model of reversible middle cerebral artery occlusion.
    Relton JK, Beckey VE, Hanson WL, Whalley ET.
    Stroke; 1997 Jul 11; 28(7):1430-6. PubMed ID: 9227696
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat.
    Boxer PA, Cordon JJ, Mann ME, Rodolosi LC, Vartanian MG, Rock DM, Taylor CP, Marcoux FW.
    Stroke; 1990 Nov 11; 21(11 Suppl):III47-51. PubMed ID: 2237985
    [Abstract] [Full Text] [Related]

  • 13. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
    Petty MA, Neumann-Haefelin C, Kalisch J, Sarhan S, Wettstein JG, Juretschke HP.
    Eur J Pharmacol; 2003 Aug 01; 474(1):53-62. PubMed ID: 12909195
    [Abstract] [Full Text] [Related]

  • 14. Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: neurological and histological validation.
    Belayev L, Busto R, Zhao W, Fernandez G, Ginsberg MD.
    Brain Res; 1999 Jul 03; 833(2):181-90. PubMed ID: 10375693
    [Abstract] [Full Text] [Related]

  • 15. The effect of bone morphogenetic protein-7 (BMP-7) on functional recovery, local cerebral glucose utilization and blood flow after transient focal cerebral ischemia in rats.
    Liu Y, Belayev L, Zhao W, Busto R, Saul I, Alonso O, Ginsberg MD.
    Brain Res; 2001 Jun 29; 905(1-2):81-90. PubMed ID: 11423082
    [Abstract] [Full Text] [Related]

  • 16. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats.
    Schäbitz WR, Schwab S, Spranger M, Hacke W.
    J Cereb Blood Flow Metab; 1997 May 29; 17(5):500-6. PubMed ID: 9183287
    [Abstract] [Full Text] [Related]

  • 17. Protection against blood-brain barrier disruption in focal cerebral ischemia by the type IV phosphodiesterase inhibitor BBB022: a quantitative study.
    Belayev L, Busto R, Ikeda M, Rubin LL, Kajiwara A, Morgan L, Ginsberg MD.
    Brain Res; 1998 Mar 23; 787(2):277-85. PubMed ID: 9518648
    [Abstract] [Full Text] [Related]

  • 18. Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage.
    Melani A, Pantoni L, Corsi C, Bianchi L, Monopoli A, Bertorelli R, Pepeu G, Pedata F.
    Stroke; 1999 Nov 23; 30(11):2448-54; discussion 2455. PubMed ID: 10548683
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
    Takaoka S, Bart RD, Pearlstein R, Brinkhous A, Warner DS.
    J Cereb Blood Flow Metab; 1997 Feb 23; 17(2):161-7. PubMed ID: 9040495
    [Abstract] [Full Text] [Related]

  • 20. sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion.
    Harukuni I, Bhardwaj A, Shaivitz AB, DeVries AC, London ED, Hurn PD, Traystman RJ, Kirsch JR, Faraci FM.
    Stroke; 2000 Apr 23; 31(4):976-82. PubMed ID: 10754008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.